No bio added yet
No link addedPalantir keeps growing while its stock sinks toward a yearly low, and that mismatch could create a chance for patient buyers. The story leans on rising demand for its AI and data software—especially from major defense programs—while laying out a step-by-step plan for buying dips and taking profits.Read more